These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11390611)

  • 21. Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter.
    Kadoya H; Nagano-Fujii M; Deng L; Nakazono N; Hotta H
    Microbiol Immunol; 2005; 49(3):265-73. PubMed ID: 15782000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.
    Sede M; Laufer N; Ojeda D; Gun A; Cahn P; Quarleri J
    Arch Virol; 2013 Sep; 158(9):1907-15. PubMed ID: 23553458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?
    Squadrito G; Raffa G; Restuccia T; Pollicino T; Brancatelli S; Raimondo G
    J Viral Hepat; 2002 Sep; 9(5):360-9. PubMed ID: 12225331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.
    Kumthip K; Chusri P; Jilg N; Zhao L; Fusco DN; Zhao H; Goto K; Cheng D; Schaefer EA; Zhang L; Pantip C; Thongsawat S; O'Brien A; Peng LF; Maneekarn N; Chung RT; Lin W
    J Virol; 2012 Aug; 86(16):8581-91. PubMed ID: 22674974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication.
    Bonte D; François C; Castelain S; Wychowski C; Dubuisson J; Meurs EF; Duverlie G
    Arch Virol; 2004 Jul; 149(7):1353-71. PubMed ID: 15221536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
    de Lucas S; Bartolome J; Carreno V
    J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
    Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
    J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of HCV NS5A on STAT1 phosphorylation and nuclear translocation induced by IFN alpha-2b].
    Cao J; Zhou Y; Gong GZ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):894-7. PubMed ID: 17196131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A.
    Ezelle HJ; Balachandran S; Sicheri F; Polyak SJ; Barber GN
    Virology; 2001 Mar; 281(1):124-37. PubMed ID: 11222103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients.
    Bolcic F; Laufer N; Torres C; Cassino L; Reynoso R; Quarleri J
    Antiviral Res; 2012 Aug; 95(2):72-81. PubMed ID: 22683884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity.
    Castelain S; Khorsi H; Roussel J; François C; Jaillon O; Capron D; Penin F; Wychowski C; Meurs E; Duverlie G;
    J Infect Dis; 2002 Mar; 185(5):573-83. PubMed ID: 11865413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
    Duverlie G; Khorsi H; Castelain S; Jaillon O; Izopet J; Lunel F; Eb F; Penin F; Wychowski C
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1373-81. PubMed ID: 9634077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C Virus Nonstructural 5A Protein (HCV-NS5A) Inhibits Hepatocyte Apoptosis through the NF-κb/miR-503/bcl-2 Pathway.
    Xie Z; Xiao Z; Wang F
    Mol Cells; 2017 Mar; 40(3):202-210. PubMed ID: 28343379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment.
    Kang SM; Won SJ; Lee GH; Lim YS; Hwang SB
    FEBS Lett; 2010 Sep; 584(18):4069-76. PubMed ID: 20804757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
    Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
    J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase.
    Sarcar B; Ghosh AK; Steele R; Ray R; Ray RB
    Virology; 2004 Apr; 322(1):51-60. PubMed ID: 15063116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway.
    Heim MH; Moradpour D; Blum HE
    J Virol; 1999 Oct; 73(10):8469-75. PubMed ID: 10482599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.
    Uzicanin S; Hu YW; Alsousi H; Pelchat M; Rocheleau L; Nair RC; Brown EG
    J Med Virol; 2012 Oct; 84(10):1571-85. PubMed ID: 22930505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.